Not sure of why the wall street journal would report misinformation could of been as simple as not getting their fact right or some sort of hidden agenda.
I just recieved this email from CASSA
An article published Friday in the Wall Street Journal that stated that the "Food and Drug Administration has been in discussions with the e-cigarette industry about a possible online-sales ban of the product" was updated with a correction later in the day. The article was changed from its original version to reflect that the Food and Drug Administration did not actually initiate the idea of a proposed ban on online sales of e-cigarettes. It also clarified that the FDA did not make nonpublic information available in its discussions with e-cigarette makers.
According to the updated article:
CASAA has stated that it will issue a Call to Action regarding the deeming regulations once the FDA actually posts the proposed regulations for public comment. The FDA has announced that those proposed regulations should be made public in October.
I just recieved this email from CASSA
An article published Friday in the Wall Street Journal that stated that the "Food and Drug Administration has been in discussions with the e-cigarette industry about a possible online-sales ban of the product" was updated with a correction later in the day. The article was changed from its original version to reflect that the Food and Drug Administration did not actually initiate the idea of a proposed ban on online sales of e-cigarettes. It also clarified that the FDA did not make nonpublic information available in its discussions with e-cigarette makers.
According to the updated article:
"Mr. Zeller said the FDA didn't release any nonpublic information in the listening sessions and didn't weigh in "on potential regulatory options-including any potential restrictions on e-cigarettes or any other particular product category." He said that any proposed rules will be issued to all interested parties at the same time."
Because CASAA will be meeting with an FDA panel for a listening session on Monday (to discuss the ramifications for its members with potential regulations), the organization asked its members via it's social media outlets to refrain from contacting the FDA regarding the Wall Street Journal article until more information was available.CASAA has stated that it will issue a Call to Action regarding the deeming regulations once the FDA actually posts the proposed regulations for public comment. The FDA has announced that those proposed regulations should be made public in October.
So it's part of the discussion, but we don't know their stance yet. Waiting game again.